The infant and toddler with wheezing

Area of Science:

• Pediatrics
• Pulmonology
• Immunology

Background:

• Recurrent wheezing affects 50% of children under six, often triggered by viral respiratory infections.
• Bacterial colonization may also contribute to recurrent wheeze and asthma development.
• Wheezing phenotypes vary, with persistent cases linked to immunoglobulin E (IgE) and atopy.

Purpose of the Study:

• To review the causes, classification, and management of recurrent wheezing in infants and toddlers.
• To discuss the utility of asthma predictive indices for early identification of high-risk children.
• To examine current treatment strategies and the need for further research into asthma development.

Main Methods:

• Literature review of studies on infant wheezing, viral and bacterial pathogens, and asthma development.
• Analysis of existing asthma predictive indices and National Asthma Education and Prevention Program (NAEPP) guidelines.
• Evaluation of treatment outcomes for inhaled corticosteroids and macrolide antibiotics in young children.

Main Results:

• Viral infections are primary triggers for early wheezing episodes.
• Asthma predictive indices can help identify children at high risk for persistent asthma.
• Inhaled corticosteroids manage symptoms but do not alter disease progression.

Conclusions:

• Wheezing in young children requires phenotype-specific management, often tailored to individual needs.
• Further research is crucial to understand asthma development mechanisms and optimize treatment in preschoolers.
• Early intervention strategies, including potential roles for antibiotics, warrant further investigation.